Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of bevacizumab when given in combination with
gemcitabine and oxaliplatin and to see what effects (good or bad) it has on patients with
hepatocellular carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Dana-Farber Cancer Institute Eli Lilly and Company Genentech, Inc. Sanofi-Synthelabo